H-K-ATPase in distal renal tubular acidosis: urinary tract obstruction, lithium, and amiloride
- PMID: 8285219
- DOI: 10.1152/ajprenal.1993.265.6.F875
H-K-ATPase in distal renal tubular acidosis: urinary tract obstruction, lithium, and amiloride
Abstract
In previous studies we suggested that urinary tract obstruction and chronic administration of lithium or amiloride were models of "voltage-dependent" distal renal tubular acidosis (DRTA). Subsequently, differences among these three models suggested that the pathogenesis was far more complex than we originally proposed. A recent study showed that H-adenosinetriphosphatase (H-ATPase) activity was decreased in all three experimental models. In the current experiments we examined the effect of 24-h unilateral ureteral obstruction (UUO) and chronic administration of amiloride and lithium on collecting tubule H-K-ATPase, the other renal H-ATPase enzyme. In the obstructed kidney, cortical collecting tubule (CCT) H-K-ATPase activity was enhanced by 73 +/- 10.0%, whereas the enzyme activity in medullary collecting tubule (MCT) was decreased by 67 +/- 5.4%. In the normal contralateral kidney, activities of H-ATPase, H-K-ATPase, and Na-K-ATPase were increased by approximately 30% in both CCT and MCT. Following amiloride (3 mg.kg-1.day-1 x 3 days ip), rats had normal acid-base status, slight hyperkalemia, and markedly elevated plasma aldosterone levels. Both CCT and MCT H-K-ATPase activities in amiloride-treated rats were unchanged. After LiCl (4 meq.kg-1.day-1 x 3 days ip), rats developed mild metabolic acidosis and had normokalemia and normal aldosterone status. CCT H-K-ATPase activity in lithium-treated rats was decreased by 64 +/- 8.8%, whereas the enzyme activity in MCT remained unchanged. Lithium in vitro (30 meq/l) inhibited CCT, but not MCT, H-K-ATPase activity, whereas amiloride had no effect on the enzyme activity. (ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Effect of lithium and amiloride on collecting tubule transport enzymes.J Pharmacol Exp Ther. 1992 May;261(2):701-6. J Pharmacol Exp Ther. 1992. PMID: 1315862
-
Effect of furosemide-induced hypokalemic metabolic alkalosis on renal transport enzymes.Kidney Int. 1993 May;43(5):1015-20. doi: 10.1038/ki.1993.143. Kidney Int. 1993. PMID: 8389946
-
Studies on the mechanism of trimethoprim-induced hyperkalemia.Kidney Int. 1996 May;49(5):1372-8. doi: 10.1038/ki.1996.193. Kidney Int. 1996. PMID: 8731102
-
[An experimental model of renal tubular acidosis--with special reference to distal renal tubular acidosis].Nihon Rinsho. 1985 Sep;43(9):1978-82. Nihon Rinsho. 1985. PMID: 3937920 Review. Japanese. No abstract available.
-
Distribution and function of the renal ATPase (H(+)-ATPase).Semin Nephrol. 1991 Jan;11(1):37-44. Semin Nephrol. 1991. PMID: 1825519 Review. No abstract available.
Cited by
-
Effects of chronic lithium administration on renal acid excretion in humans and rats.Physiol Rep. 2014 Dec 11;2(12):e12242. doi: 10.14814/phy2.12242. Print 2014 Dec 1. Physiol Rep. 2014. PMID: 25501430 Free PMC article.
-
Revisiting voltage-coupled H+ secretion in the collecting duct.Am J Physiol Renal Physiol. 2024 Dec 1;327(6):F931-F945. doi: 10.1152/ajprenal.00023.2024. Epub 2024 Sep 26. Am J Physiol Renal Physiol. 2024. PMID: 39323388 Review.
-
P2C-Type ATPases and Their Regulation.Mol Neurobiol. 2016 Mar;53(2):1343-1354. doi: 10.1007/s12035-014-9076-z. Epub 2015 Jan 29. Mol Neurobiol. 2016. PMID: 25631710 Review.
-
Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety.CNS Drugs. 2009;23(5):397-418. doi: 10.2165/00023210-200923050-00004. CNS Drugs. 2009. PMID: 19453201 Review.
-
Acetazolamide Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus.J Am Soc Nephrol. 2016 Jul;27(7):2082-91. doi: 10.1681/ASN.2015070796. Epub 2015 Nov 16. J Am Soc Nephrol. 2016. PMID: 26574046 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources